Napoleone et al. [18] demonstrated that downregulation of rennin–angiotensin system by ACE inhibitors and angiotensin receptor blockers inhibits tissue factor and VEGF expression in highly metastatic breast cancer cells. Here, ACE is linked to breast cancer.